GlassScriptPhysician profile
Johnnie Lee Byrd
NPI 1710208491
$2,040.17
in general payments reported to CMS, 2019-2025
16 companies · $14.88 in 2025
The $14.88 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $163 · 2020: $26.89 · 2021: $312 · 2022: $845 · 2023: $678 · 2025: $14.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $693.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $692.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $526.84 | 2021-2023 | |
| Janssen Pharmaceuticals, INC | $440.82 | 2021-2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $161.13 | 2019-2023 | Jardiance |
| Pfizer INC. | $133.82 | 2022-2023 | |
| Glaxosmithkline, LLC. | $117.29 | 2022-2023 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals LP | $111.93 | 2019-2023 | Breztri, Farxiga |
| Amarin Pharma, INC. | $89.20 | 2019-2022 | |
| Lilly USA, LLC | $86.61 | 2022-2023 | Jardiance, Mounjaro |
| Novo Nordisk INC | $85.32 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $74.22 | 2022-2023 | |
| Abbott Laboratories | $71.80 | 2021-2022 | |
| Smith+Nephew, INC. | $50.12 | 2023 | Collagenase Santyl |
| Novartis Pharmaceuticals Corporation | $45.94 | 2022-2023 | |
| Regeneron Healthcare Solutions, INC. | $16.26 | 2023 | Evkeeza |
| Amgen INC. | $14.88 | 2025 | Krystexxa |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $13.99 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Johnnie Byrd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.